Structural Insights into the ADCC Mechanism and Resistance of Mogamulizumab, a First-in-Class Anti-CCR4 Therapy for Cutaneous T Cell Lymphoma
莫加莫珠单抗（一种用于治疗皮肤T细胞淋巴瘤的首创抗CCR4疗法）的ADCC机制和耐药性的结构解析
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26125500
Choi, Seung Beom; Lee, Hyun Tae; Gu, Nahyeon; Jang, Yu-Jeong; Park, Ui Beom; Jeong, Tae Jun; Lee, Sang Hyung; Heo, Yong-Seok
